• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cloud Market
Cloud News
Cloud Stocks
  • Cloud Market
  • Cloud News
  • Cloud Stocks
cloud-investing

Seven Bridges Goes Live With Cancer Genomics Cloud Pilot

Vivien Diniz
Feb. 16, 2016 09:43AM PST
Cloud Investing

Seven Bridges today announced that the system it was selected to develop as part of the National Cancer Institute’s Cloud pilot program is open to researchers worldwide. The Seven Bridges Cancer Genomics Cloud is the first complete ecosystem to give cancer researchers immediate access to one of the world’s largest genomic datasets — The Cancer Genome Atlas (TCGA) — and the computational resources to analyze it.

Seven Bridges today announced that the system it was selected to develop as part of the National Cancer Institute’s Cloud pilot program is open to researchers worldwide. The Seven Bridges Cancer Genomics Cloud is the first complete ecosystem to give cancer researchers immediate access to one of the world’s largest genomic datasets — The Cancer Genome Atlas (TCGA) — and the computational resources to analyze it.
According to the company’s press release:

The Seven Bridges pilot makes more than a petabyte of multi-dimensional data available immediately to researchers, who can also add their own data to analyze alongside TCGA. As an NIH Trusted Partner, Seven Bridges can also authenticate and authorize access to controlled data within TCGA to ensure only NIH-approved researchers may use it.

Dr. Tony Kerlavage, Chief of the Cancer Informatics Branch in the Center for Biomedical Informatics and Information Technology (CBIIT) at the National Cancer Institute commented:

Next-generation sequencing has opened the door to new breakthroughs in precision medicine, but the massive data volumes involved also present significant storage and computing challenges. Our goal is to democratize access to NCI-generated genomic and related data and to create a cost-effective way to provide an analytical framework to the cancer research community.

Click here to view the full press release. 

cancer-research precision-medicine cloud-investing
The Conversation (0)

Go Deeper

AI Powered
Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Cloud Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES